Time New York: Thu 14 Dec 19:47 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Why Hold Strategy is Suitable for Franklin (BEN) Stock Now

Zacks

On Nov 30, we issued an updated research report on Franklin Resources BEN. The company has been benefiting from expense management and strong diversification strategies. However, declining investment management fees and strict regulatory environment remain the near-term concerns for this Zacks Rank #3 (Hold) stock.

The company’s earnings estimates for fiscal 2017 have been revised marginally upward in the last 60 days.

Franklin’s shares have gained 10.5% in a year’s time, underperforming the industry’s rally of 29.2%.


The company remains focused on cost control. Franklin recorded 7%, 14% and 3% decline in operating expenses in fiscal 2015, 2016 and 2017, respectively. While potential investments in the technology may escalate expenses in fiscal 2018, previous cost-cutting initiatives are expected to support the top line.

Also, Franklin has grown through strategic acquisitions in the last couple of years. Such acquisitions will support the company in improving and expanding its alternative investments and multi-asset solutions platforms, which in turn are likely to help it provide world-class investment solutions to clients.

However, the company’s AUM is exposed to market fluctuations and foreign exchange translations, regulatory changes or a sudden slowdown in overall business activities. Notably, during fiscals 2016 and 2017, fees declined due to reduced average AUM and lower effective fee rate.

Further, the business and regulatory environment in which Franklin operates continues to be complex and uncertain. Additionally, it remains subject to numerous regulations by U.S. and non-U.S. regulators that further increases complexity to ongoing global compliance operations and thereby hurt profitability.

Some better-ranked stocks in the same space include AllianceBernstein Holding L.P. AB, Hamilton Lane Incorporated HLNE and Waddell & Reed Financial WDR. All these stocks carry a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

AllianceBernstein Holding has witnessed an upward earnings estimate revision of one cent per share for the current year, in the last 60 days. Also, its shares have gained 6.6% year to date.

Hamilton Lane Incorporated’s current-year earnings estimates have been revised upward by 6.5%, in the last 60 days. Also, on a year-to-date basis, its shares have surged 91.3%.

Waddell & Reed Financial has witnessed an upward earnings estimate revision of 5.6% for the current year, in the last 60 days. The company’s shares have gained 4.1% year to date.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.